BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 18606981)

  • 1. Allogeneic hematopoietic stem-cell transplantation for myeloid sarcoma: a retrospective study from the SFGM-TC.
    Chevallier P; Mohty M; Lioure B; Michel G; Contentin N; Deconinck E; Bordigoni P; Vernant JP; Hunault M; Vigouroux S; Blaise D; Tabrizi R; Buzyn A; Socie G; Michallet M; Volteau C; Harousseau JL
    J Clin Oncol; 2008 Oct; 26(30):4940-3. PubMed ID: 18606981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term outcome after allogeneic hematopoietic stem cell transplantation for advanced stage acute myeloblastic leukemia: a retrospective study of 379 patients reported to the Société Française de Greffe de Moelle (SFGM).
    Michallet M; Thomas X; Vernant JP; Kuentz M; Socié G; Espérou-Bourdeau H; Milpied N; Blaise D; Rio B; Reiffers J; Jouet JP; Cahn JY; Bourhis JH; Lioure B; Leporrier M; Sotto JJ; Souillet G; Sutton L; Bordigoni P; Dreyfus F; Tilly H; Gratecos N; Attal M; Leprise PY; Déméocq F; Michel G; Buzyn A; Delmas-Marsalet B; Bernaudin F; Ifrah N; Sadoun A; Guyotat D; Cavazzana-Cavo M; Caillot D; De Revel T; Vannier JP; Baruchel A; Fegueux N; Tanguy ML; Thiébaut A; Belhabri A; Archimbaud E
    Bone Marrow Transplant; 2000 Dec; 26(11):1157-63. PubMed ID: 11149725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autologous hematopoietic stem-cell transplantation for children with acute myeloid leukemia in first or second complete remission: a prognostic factor analysis.
    Godder K; Eapen M; Laver JH; Zhang MJ; Camitta BM; Wayne AS; Gale RP; Doyle JJ; Yu LC; Chen AR; Garvin JH; Sandler ES; Yeager AM; Edwards JR; Horowitz MM
    J Clin Oncol; 2004 Sep; 22(18):3798-804. PubMed ID: 15365077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autologous hematopoietic stem cell transplantation as an intensive consolidation therapy for adult patients in remission from acute myelogenous leukemia.
    Jung AS; Holman PR; Castro JE; Carrier EK; Bashey A; Lane TA; Nelson CL; Pu M; Messer K; Corringham SM; Ball ED
    Biol Blood Marrow Transplant; 2009 Oct; 15(10):1306-13. PubMed ID: 19747639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allogeneic hematopoietic stem cell transplantation for adult AML patients with granulocytic sarcoma.
    Shimizu H; Saitoh T; Tanaka M; Mori T; Sakura T; Kawai N; Kanda Y; Nakaseko C; Yano S; Fujita H; Fujisawa S; Miyawaki S; Kanamori H; Okamoto S
    Leukemia; 2012 Dec; 26(12):2469-73. PubMed ID: 22699453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative analysis of the value of allogeneic hematopoietic stem-cell transplantation in acute myeloid leukemia with monosomal karyotype versus other cytogenetic risk categories.
    Cornelissen JJ; Breems D; van Putten WL; Gratwohl AA; Passweg JR; Pabst T; Maertens J; Beverloo HB; van Marwijk Kooy M; Wijermans PW; Biemond BJ; Vellenga E; Verdonck LF; Ossenkoppele GJ; Löwenberg B
    J Clin Oncol; 2012 Jun; 30(17):2140-6. PubMed ID: 22564995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Donor lymphocyte infusion in the treatment of first hematological relapse after allogeneic stem-cell transplantation in adults with acute myeloid leukemia: a retrospective risk factors analysis and comparison with other strategies by the EBMT Acute Leukemia Working Party.
    Schmid C; Labopin M; Nagler A; Bornhäuser M; Finke J; Fassas A; Volin L; Gürman G; Maertens J; Bordigoni P; Holler E; Ehninger G; Polge E; Gorin NC; Kolb HJ; Rocha V;
    J Clin Oncol; 2007 Nov; 25(31):4938-45. PubMed ID: 17909197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Matched unrelated or matched sibling donors result in comparable survival after allogeneic stem-cell transplantation in elderly patients with acute myeloid leukemia: a report from the cooperative German Transplant Study Group.
    Schetelig J; Bornhäuser M; Schmid C; Hertenstein B; Schwerdtfeger R; Martin H; Stelljes M; Hegenbart U; Schäfer-Eckart K; Füssel M; Wiedemann B; Thiede C; Kienast J; Baurmann H; Ganser A; Kolb HJ; Ehninger G
    J Clin Oncol; 2008 Nov; 26(32):5183-91. PubMed ID: 18768435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complete remission status before autologous stem cell transplantation is an important prognostic factor in patients with multiple myeloma undergoing upfront single autologous transplantation.
    Kim JS; Kim K; Cheong JW; Min YH; Suh C; Kim H; Jo DY; Ryoo HM; Yoon SS; Lee JH;
    Biol Blood Marrow Transplant; 2009 Apr; 15(4):463-70. PubMed ID: 19285634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hematopoietic stem cell transplantation for adults with acute promyelocytic leukemia in the ATRA era: a survey of the European Cooperative Group for Blood and Marrow Transplantation.
    Sanz MA; Labopin M; Gorin NC; de la Rubia J; Arcese W; Meloni G; Bacigalupo A; Alessandrino P; Carreras E; Iriondo A; Novitzky N; Jacobs P; Bandini G; Lo-Coco F; Frassoni F; Rocha V;
    Bone Marrow Transplant; 2007 Apr; 39(8):461-9. PubMed ID: 17322930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allogeneic stem cell transplantation for adults with myelodysplastic syndromes: importance of pretransplant disease burden.
    Warlick ED; Cioc A; Defor T; Dolan M; Weisdorf D
    Biol Blood Marrow Transplant; 2009 Jan; 15(1):30-8. PubMed ID: 19135940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Results of risk-adapted therapy in acute myeloid leukaemia. A long-term population-based follow-up study.
    Wahlin A; Billström R; Björ O; Ahlgren T; Hedenus M; Höglund M; Lindmark A; Markevärn B; Nilsson B; Sallerfors B; Brune M
    Eur J Haematol; 2009 Aug; 83(2):99-107. PubMed ID: 19385987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identical outcome after autologous or allogeneic genoidentical hematopoietic stem-cell transplantation in first remission of acute myelocytic leukemia carrying inversion 16 or t(8;21): a retrospective study from the European Cooperative Group for Blood and Marrow Transplantation.
    Gorin NC; Labopin M; Frassoni F; Milpied N; Attal M; Blaise D; Meloni G; Iori AP; Michallet M; Willemze R; Deconninck E; Harousseau JL; Polge E; Rocha V
    J Clin Oncol; 2008 Jul; 26(19):3183-8. PubMed ID: 18506024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term outcomes of de novo acute myeloid leukemia in Thai patients.
    Niparuck P; Chuncharunee S; Ungkanont A; Udomtrupayakul U; Aungchaisuksiri P; Rerkamnuatchoke B; Jootar S; Atichartakarn V
    J Med Assoc Thai; 2009 Sep; 92(9):1143-9. PubMed ID: 19772172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting survival in adults with invasive aspergillosis during therapy for hematological malignancies or after hematopoietic stem cell transplantation: Single-center analysis and validation of the Seattle, French, and Strasbourg prognostic indexes.
    Parody R; Martino R; Sánchez F; Subirá M; Hidalgo A; Sierra J
    Am J Hematol; 2009 Sep; 84(9):571-8. PubMed ID: 19676118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical implications of acute myeloid leukemia presenting as myeloid sarcoma.
    Avni B; Rund D; Levin M; Grisariu S; Ben-Yehuda D; Bar-Cohen S; Paltiel O
    Hematol Oncol; 2012 Mar; 30(1):34-40. PubMed ID: 21638303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk-stratified therapy and the intensive use of cytarabine improves the outcome in childhood acute myeloid leukemia: the AML99 trial from the Japanese Childhood AML Cooperative Study Group.
    Tsukimoto I; Tawa A; Horibe K; Tabuchi K; Kigasawa H; Tsuchida M; Yabe H; Nakayama H; Kudo K; Kobayashi R; Hamamoto K; Imaizumi M; Morimoto A; Tsuchiya S; Hanada R
    J Clin Oncol; 2009 Aug; 27(24):4007-13. PubMed ID: 19620491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sequential intensified conditioning and tapering of prophylactic immunosuppressants for graft-versus-host disease in allogeneic hematopoietic stem cell transplantation for refractory leukemia.
    Liu QF; Fan ZP; Zhang Y; Jiang ZJ; Wang CY; Xu D; Sun J; Xiao Y; Tan H
    Biol Blood Marrow Transplant; 2009 Nov; 15(11):1376-85. PubMed ID: 19822296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of nonrelapse mortality for patients surviving 100 days after allogeneic hematopoietic stem cell transplantation.
    Wojnar J; Giebel S; Holowiecka-Goral A; Markiewicz M; Wylezol I; Kopera M; Krawczyk-Kulis M; Holowiecki J
    Transplant Proc; 2007 Dec; 39(10):3375-9. PubMed ID: 18089388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Post-transplant outcome in chronic myeloid leukaemia.
    Raza S; Ullah K; Ahmed P; Khan B; Kamal MK
    J Coll Physicians Surg Pak; 2008 Oct; 18(10):615-9. PubMed ID: 18940118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.